Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 90 entries
Sorted by: Best Match Show Resources per page
Promotion and Reporting of Research from Resource-Limited Settings.

Infectious diseases

Siriwardhana C.
PMID: 26396528
Infect Dis (Auckl). 2015 Sep 06;8:25-9. doi: 10.4137/IDRT.S16195. eCollection 2015.

Driven by global burden of disease and inequalities in health care, research activities in resource-poor settings have radically increased. However, a corresponding increase in reporting of research from these settings has not been observed. This article critically explores the...

Cite
Siriwardhana C. Promotion and Reporting of Research from Resource-Limited Settings. Infect Dis (Auckl). 2015;8:25-9doi: 10.4137/IDRT.S16195.
Siriwardhana, C. (2015). Promotion and Reporting of Research from Resource-Limited Settings. Infectious diseases, 825-9. https://doi.org/10.4137/IDRT.S16195
Siriwardhana, Chesmal. "Promotion and Reporting of Research from Resource-Limited Settings." Infectious diseases vol. 8 (2015): 25-9. doi: https://doi.org/10.4137/IDRT.S16195
Siriwardhana C. Promotion and Reporting of Research from Resource-Limited Settings. Infect Dis (Auckl). 2015 Sep 06;8:25-9. doi: 10.4137/IDRT.S16195. eCollection 2015. PMID: 26396528; PMCID: PMC4562664.
Copy Download .nbib Format: NLM
Assessing Healthcare Utilization for Influenza-like Illness at an Emergency Department and a Student Health Service during the 2009-2010 H1N1 Pandemic.

Infectious diseases

Bhandari R, Hartley TA, Lindsley WG, Fisher MA, Palmer JE.
PMID: 24847173
Infect Dis (Auckl). 2013 Mar 07;6:15-23. doi: 10.4137/IDRT.S11315. eCollection 2013.

Estimates of healthcare utilization during an influenza pandemic are needed in order to plan for the allocation of staff and resources. The aim of this study was to assess the number, age, and arrival time of patients with influenza-like-illness...

Cite
Bhandari R, Hartley TA, Lindsley WG, et al. Assessing Healthcare Utilization for Influenza-like Illness at an Emergency Department and a Student Health Service during the 2009-2010 H1N1 Pandemic. Infect Dis (Auckl). 2013;6:15-23doi: 10.4137/IDRT.S11315.
Bhandari, R., Hartley, T. A., Lindsley, W. G., Fisher, M. A., & Palmer, J. E. (2013). Assessing Healthcare Utilization for Influenza-like Illness at an Emergency Department and a Student Health Service during the 2009-2010 H1N1 Pandemic. Infectious diseases, 615-23. https://doi.org/10.4137/IDRT.S11315
Bhandari, Ruchi, et al. "Assessing Healthcare Utilization for Influenza-like Illness at an Emergency Department and a Student Health Service during the 2009-2010 H1N1 Pandemic." Infectious diseases vol. 6 (2013): 15-23. doi: https://doi.org/10.4137/IDRT.S11315
Bhandari R, Hartley TA, Lindsley WG, Fisher MA, Palmer JE. Assessing Healthcare Utilization for Influenza-like Illness at an Emergency Department and a Student Health Service during the 2009-2010 H1N1 Pandemic. Infect Dis (Auckl). 2013 Mar 07;6:15-23. doi: 10.4137/IDRT.S11315. eCollection 2013. PMID: 24847173; PMCID: PMC3988625.
Copy Download .nbib Format: NLM
Clinical Profile and Prognostic Indicators in Adults Hospitalized with Severe Malaria Caused by Different Plasmodium Species.

Infectious diseases

Gupta BK, Gupta A, Nehra HR, Balotia HR, Meena SL, Kumar S.
PMID: 26692763
Infect Dis (Auckl). 2015 Dec 06;8:45-50. doi: 10.4137/IDRT.S34039. eCollection 2015.

INTRODUCTION: Severe malaria remains a major cause of death and morbidity among adults in the Asiatic tropics. This study was planned to evaluate clinical profile and prognostic indicators of severe malaria in adults so as to improve insight into...

Cite
Gupta BK, Gupta A, Nehra HR, et al. Clinical Profile and Prognostic Indicators in Adults Hospitalized with Severe Malaria Caused by Different Plasmodium Species. Infect Dis (Auckl). 2015;8:45-50doi: 10.4137/IDRT.S34039.
Gupta, B. K., Gupta, A., Nehra, H. R., Balotia, H. R., Meena, S. L., & Kumar, S. (2015). Clinical Profile and Prognostic Indicators in Adults Hospitalized with Severe Malaria Caused by Different Plasmodium Species. Infectious diseases, 845-50. https://doi.org/10.4137/IDRT.S34039
Gupta, Bal Kishan, et al. "Clinical Profile and Prognostic Indicators in Adults Hospitalized with Severe Malaria Caused by Different Plasmodium Species." Infectious diseases vol. 8 (2015): 45-50. doi: https://doi.org/10.4137/IDRT.S34039
Gupta BK, Gupta A, Nehra HR, Balotia HR, Meena SL, Kumar S. Clinical Profile and Prognostic Indicators in Adults Hospitalized with Severe Malaria Caused by Different Plasmodium Species. Infect Dis (Auckl). 2015 Dec 06;8:45-50. doi: 10.4137/IDRT.S34039. eCollection 2015. PMID: 26692763; PMCID: PMC4671546.
Copy Download .nbib Format: NLM
Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis.

Infectious diseases

Villar J, Short JH, Lighthall G.
PMID: 31431799
Infect Dis (Auckl). 2019 Aug 06;12:1178633719862776. doi: 10.1177/1178633719862776. eCollection 2019.

OBJECTIVE: To measure the relationship between lactate and mortality in hospital inpatients. Main outcomes of interest were 3-day, 30-day, and 1-year all-cause mortality.DESIGN: Retrospective cohort study, October 2011 to September 2013.SETTING: University-affiliated US Veterans Affairs Hospital.PATIENTS: All inpatients with...

Cite
Villar J, Short JH, Lighthall G. Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis. Infect Dis (Auckl). 2019;12:1178633719862776doi: 10.1177/1178633719862776.
Villar, J., Short, J. H., & Lighthall, G. (2019). Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis. Infectious diseases, 121178633719862776. https://doi.org/10.1177/1178633719862776
Villar, Julian, et al. "Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis." Infectious diseases vol. 12 (2019): 1178633719862776. doi: https://doi.org/10.1177/1178633719862776
Villar J, Short JH, Lighthall G. Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis. Infect Dis (Auckl). 2019 Aug 06;12:1178633719862776. doi: 10.1177/1178633719862776. eCollection 2019. PMID: 31431799; PMCID: PMC6686323.
Copy Download .nbib Format: NLM
Tetanus, Diphtheria, and Acellular Pertussis and Influenza Vaccinations among Women With a Live Birth, Internet Panel Survey, 2017-2018.

Infectious diseases

Murthy NC, Black C, Kahn KE, Ding H, Ball S, Fink RV, Devlin R, D'Angelo D, Fiebelkorn AP.
PMID: 32095076
Infect Dis (Auckl). 2020 Feb 10;13:1178633720904099. doi: 10.1177/1178633720904099. eCollection 2020.

OBJECTIVES: Pregnant women are at increased risk of complications from influenza, and infants are at increased risk of pertussis. Maternal influenza and Tdap (tetanus, diphtheria, and acellular pertussis) vaccination can reduce risk of these infections and related complications. Our...

Cite
Murthy NC, Black C, Kahn KE, et al. Tetanus, Diphtheria, and Acellular Pertussis and Influenza Vaccinations among Women With a Live Birth, Internet Panel Survey, 2017-2018. Infect Dis (Auckl). 2020;13:1178633720904099doi: 10.1177/1178633720904099.
Murthy, N. C., Black, C., Kahn, K. E., Ding, H., Ball, S., Fink, R. V., Devlin, R., D'Angelo, D., & Fiebelkorn, A. P. (2020). Tetanus, Diphtheria, and Acellular Pertussis and Influenza Vaccinations among Women With a Live Birth, Internet Panel Survey, 2017-2018. Infectious diseases, 131178633720904099. https://doi.org/10.1177/1178633720904099
Murthy, Neil Chandra, et al. "Tetanus, Diphtheria, and Acellular Pertussis and Influenza Vaccinations among Women With a Live Birth, Internet Panel Survey, 2017-2018." Infectious diseases vol. 13 (2020): 1178633720904099. doi: https://doi.org/10.1177/1178633720904099
Murthy NC, Black C, Kahn KE, Ding H, Ball S, Fink RV, Devlin R, D'Angelo D, Fiebelkorn AP. Tetanus, Diphtheria, and Acellular Pertussis and Influenza Vaccinations among Women With a Live Birth, Internet Panel Survey, 2017-2018. Infect Dis (Auckl). 2020 Feb 10;13:1178633720904099. doi: 10.1177/1178633720904099. eCollection 2020. PMID: 32095076; PMCID: PMC7011328.
Copy Download .nbib Format: NLM
Efficacy of Single Dose Ivermectin Against .

Infectious diseases

Hailu T, Nibret E, Amor A, Munshea A, Anegagrie M.
PMID: 32595279
Infect Dis (Auckl). 2020 Jun 15;13:1178633720932544. doi: 10.1177/1178633720932544. eCollection 2020.

BACKGROUND: Ivermectin has been proven to be highly effective against OBJECTIVE: This study aimed to evaluate the efficacy of single dose ivermectin against METHODS: Stool sample was collected from April 2019 to December 2019 among 844 school children and...

Cite
Hailu T, Nibret E, Amor A, et al. Efficacy of Single Dose Ivermectin Against . Infect Dis (Auckl). 2020;13:1178633720932544doi: 10.1177/1178633720932544.
Hailu, T., Nibret, E., Amor, A., Munshea, A., & Anegagrie, M. (2020). Efficacy of Single Dose Ivermectin Against . Infectious diseases, 131178633720932544. https://doi.org/10.1177/1178633720932544
Hailu, Tadesse, et al. "Efficacy of Single Dose Ivermectin Against ." Infectious diseases vol. 13 (2020): 1178633720932544. doi: https://doi.org/10.1177/1178633720932544
Hailu T, Nibret E, Amor A, Munshea A, Anegagrie M. Efficacy of Single Dose Ivermectin Against . Infect Dis (Auckl). 2020 Jun 15;13:1178633720932544. doi: 10.1177/1178633720932544. eCollection 2020. PMID: 32595279; PMCID: PMC7297470.
Copy Download .nbib Format: NLM
High Prevalence of Multi-Drug Resistance and Extended Spectrum Beta Lactamase Production in Non-Fermenting Gram-Negative Bacilli in Ethiopia.

Infectious diseases

Bitew A.
PMID: 31723320
Infect Dis (Auckl). 2019 Nov 05;12:1178633719884951. doi: 10.1177/1178633719884951. eCollection 2019.

BACKGROUND: Emergence of resistance to multiple antimicrobial agents in Non-Fermenting Gram-Negative Bacilli is a major problem to public health, as it limits drug treatment options against infections. The aim of this study was to determine the prevalence of multi-drug...

Cite
Bitew A. High Prevalence of Multi-Drug Resistance and Extended Spectrum Beta Lactamase Production in Non-Fermenting Gram-Negative Bacilli in Ethiopia. Infect Dis (Auckl). 2019;12:1178633719884951doi: 10.1177/1178633719884951.
Bitew, A. (2019). High Prevalence of Multi-Drug Resistance and Extended Spectrum Beta Lactamase Production in Non-Fermenting Gram-Negative Bacilli in Ethiopia. Infectious diseases, 121178633719884951. https://doi.org/10.1177/1178633719884951
Bitew, Adane. "High Prevalence of Multi-Drug Resistance and Extended Spectrum Beta Lactamase Production in Non-Fermenting Gram-Negative Bacilli in Ethiopia." Infectious diseases vol. 12 (2019): 1178633719884951. doi: https://doi.org/10.1177/1178633719884951
Bitew A. High Prevalence of Multi-Drug Resistance and Extended Spectrum Beta Lactamase Production in Non-Fermenting Gram-Negative Bacilli in Ethiopia. Infect Dis (Auckl). 2019 Nov 05;12:1178633719884951. doi: 10.1177/1178633719884951. eCollection 2019. PMID: 31723320; PMCID: PMC6836305.
Copy Download .nbib Format: NLM
Pharmacology, Phytochemistry, and Toxicity Profiles of .

Infectious diseases

Beressa TB, Ajayi CO, Peter EL, Okella H, Ogwang PE, Anke W, Tolo CU.
PMID: 32782430
Infect Dis (Auckl). 2020 Jul 27;13:1178633720943509. doi: 10.1177/1178633720943509. eCollection 2020.

METHODS: We searched without language restriction in MEDLINE, Google Scholar, Scopus, Embase, and Web of Science through December 2019. Both published and unpublished articles were assessed for relevance and reviewed.RESULTS: Of 600 articles retrieved through database search, a total...

Cite
Beressa TB, Ajayi CO, Peter EL, et al. Pharmacology, Phytochemistry, and Toxicity Profiles of . Infect Dis (Auckl). 2020;13:1178633720943509doi: 10.1177/1178633720943509.
Beressa, T. B., Ajayi, C. O., Peter, E. L., Okella, H., Ogwang, P. E., Anke, W., & Tolo, C. U. (2020). Pharmacology, Phytochemistry, and Toxicity Profiles of . Infectious diseases, 131178633720943509. https://doi.org/10.1177/1178633720943509
Beressa, Tamirat Bekele, et al. "Pharmacology, Phytochemistry, and Toxicity Profiles of ." Infectious diseases vol. 13 (2020): 1178633720943509. doi: https://doi.org/10.1177/1178633720943509
Beressa TB, Ajayi CO, Peter EL, Okella H, Ogwang PE, Anke W, Tolo CU. Pharmacology, Phytochemistry, and Toxicity Profiles of . Infect Dis (Auckl). 2020 Jul 27;13:1178633720943509. doi: 10.1177/1178633720943509. eCollection 2020. PMID: 32782430; PMCID: PMC7388083.
Copy Download .nbib Format: NLM
Psychological Distress and Its Correlates among Newly Diagnosed People Living with HIV in Northwest Ethiopia: Ordinal Logistic Regression Analyses.

Infectious diseases

Moges NA, Adesina OA, Okunlola MA, Berhane Y, Akinyemi JO.
PMID: 33642865
Infect Dis (Auckl). 2021 Feb 14;14:1178633721994598. doi: 10.1177/1178633721994598. eCollection 2021.

BACKGROUND: Although there is a high burden of HIV in sub-Saharan Africa (SSA), studies on mental health issues among people living with HIV are scarce. The study addressed the transition to "test and treat" guidelines for HIV, which makes...

Cite
Moges NA, Adesina OA, Okunlola MA, et al. Psychological Distress and Its Correlates among Newly Diagnosed People Living with HIV in Northwest Ethiopia: Ordinal Logistic Regression Analyses. Infect Dis (Auckl). 2021;14:1178633721994598doi: 10.1177/1178633721994598.
Moges, N. A., Adesina, O. A., Okunlola, M. A., Berhane, Y., & Akinyemi, J. O. (2021). Psychological Distress and Its Correlates among Newly Diagnosed People Living with HIV in Northwest Ethiopia: Ordinal Logistic Regression Analyses. Infectious diseases, 141178633721994598. https://doi.org/10.1177/1178633721994598
Moges, Nurilign Abebe, et al. "Psychological Distress and Its Correlates among Newly Diagnosed People Living with HIV in Northwest Ethiopia: Ordinal Logistic Regression Analyses." Infectious diseases vol. 14 (2021): 1178633721994598. doi: https://doi.org/10.1177/1178633721994598
Moges NA, Adesina OA, Okunlola MA, Berhane Y, Akinyemi JO. Psychological Distress and Its Correlates among Newly Diagnosed People Living with HIV in Northwest Ethiopia: Ordinal Logistic Regression Analyses. Infect Dis (Auckl). 2021 Feb 14;14:1178633721994598. doi: 10.1177/1178633721994598. eCollection 2021. PMID: 33642865; PMCID: PMC7890707.
Copy Download .nbib Format: NLM
Inhibition of ACE2 Expression by Ascorbic Acid Alone and its Combinations with Other Natural Compounds.

Infectious diseases

Ivanov V, Goc A, Ivanova S, Niedzwiecki A, Rath M.
PMID: 33642866
Infect Dis (Auckl). 2021 Feb 14;14:1178633721994605. doi: 10.1177/1178633721994605. eCollection 2021.

BACKGROUND: Angiotensin-converting enzyme II or ACE2 is an integral membrane protein present on many types of cells, including vascular endothelial cells and lung alveolar epithelial cells. This receptor serves as the entry point for SARS-coronaviruses (SARS-CoVs), including a novel...

Cite
Ivanov V, Goc A, Ivanova S, et al. Inhibition of ACE2 Expression by Ascorbic Acid Alone and its Combinations with Other Natural Compounds. Infect Dis (Auckl). 2021;14:1178633721994605doi: 10.1177/1178633721994605.
Ivanov, V., Goc, A., Ivanova, S., Niedzwiecki, A., & Rath, M. (2021). Inhibition of ACE2 Expression by Ascorbic Acid Alone and its Combinations with Other Natural Compounds. Infectious diseases, 141178633721994605. https://doi.org/10.1177/1178633721994605
Ivanov, Vadim, et al. "Inhibition of ACE2 Expression by Ascorbic Acid Alone and its Combinations with Other Natural Compounds." Infectious diseases vol. 14 (2021): 1178633721994605. doi: https://doi.org/10.1177/1178633721994605
Ivanov V, Goc A, Ivanova S, Niedzwiecki A, Rath M. Inhibition of ACE2 Expression by Ascorbic Acid Alone and its Combinations with Other Natural Compounds. Infect Dis (Auckl). 2021 Feb 14;14:1178633721994605. doi: 10.1177/1178633721994605. eCollection 2021. PMID: 33642866; PMCID: PMC7890723.
Copy Download .nbib Format: NLM
Prolonged Viral Shedding in Patients with Mild to Moderate COVID-19 Disease: A Regional Perspective.

Infectious diseases

Hossain ME, Lister D, Bartolo C, Kinsella PM, Knox J, Aldrich R, Cowan R, Commons RJ.
PMID: 33911876
Infect Dis (Auckl). 2021 Apr 13;14:11786337211010428. doi: 10.1177/11786337211010428. eCollection 2021.

BACKGROUND: The risk of transmission of Coronavirus Disease 2019 (COVID-19) is increasingly understood to be greatest early after symptom onset, however, factors associated with prolonged and increased risk of transmission remain unclear. In settings where COVID-19 prevalence is low,...

Cite
Hossain ME, Lister D, Bartolo C, et al. Prolonged Viral Shedding in Patients with Mild to Moderate COVID-19 Disease: A Regional Perspective. Infect Dis (Auckl). 2021;14:11786337211010428doi: 10.1177/11786337211010428.
Hossain, M. E., Lister, D., Bartolo, C., Kinsella, P. M., Knox, J., Aldrich, R., Cowan, R., & Commons, R. J. (2021). Prolonged Viral Shedding in Patients with Mild to Moderate COVID-19 Disease: A Regional Perspective. Infectious diseases, 1411786337211010428. https://doi.org/10.1177/11786337211010428
Hossain, Mehrab E, et al. "Prolonged Viral Shedding in Patients with Mild to Moderate COVID-19 Disease: A Regional Perspective." Infectious diseases vol. 14 (2021): 11786337211010428. doi: https://doi.org/10.1177/11786337211010428
Hossain ME, Lister D, Bartolo C, Kinsella PM, Knox J, Aldrich R, Cowan R, Commons RJ. Prolonged Viral Shedding in Patients with Mild to Moderate COVID-19 Disease: A Regional Perspective. Infect Dis (Auckl). 2021 Apr 13;14:11786337211010428. doi: 10.1177/11786337211010428. eCollection 2021. PMID: 33911876; PMCID: PMC8047841.
Copy Download .nbib Format: NLM
Experience With Ceftolozane-Tazobactam for the Treatment of Serious .

Infectious diseases

Bosaeed M, Ahmad A, Alali A, Mahmoud E, Alswidan L, Alsaedy A, Aljuhani S, Alalwan B, Alshamrani M, Alothman A.
PMID: 32110036
Infect Dis (Auckl). 2020 Feb 11;13:1178633720905977. doi: 10.1177/1178633720905977. eCollection 2020.

INTRODUCTION: Multidrug-resistant METHODS: A single-center retrospective observational study between January 2017 and December 2018 for patients who had been diagnosed with carbapenem-resistant RESULTS: A total of 19 patients fit the inclusion criteria, with a median age was 57 years,...

Cite
Bosaeed M, Ahmad A, Alali A, et al. Experience With Ceftolozane-Tazobactam for the Treatment of Serious . Infect Dis (Auckl). 2020;13:1178633720905977doi: 10.1177/1178633720905977.
Bosaeed, M., Ahmad, A., Alali, A., Mahmoud, E., Alswidan, L., Alsaedy, A., Aljuhani, S., Alalwan, B., Alshamrani, M., & Alothman, A. (2020). Experience With Ceftolozane-Tazobactam for the Treatment of Serious . Infectious diseases, 131178633720905977. https://doi.org/10.1177/1178633720905977
Bosaeed, M, et al. "Experience With Ceftolozane-Tazobactam for the Treatment of Serious ." Infectious diseases vol. 13 (2020): 1178633720905977. doi: https://doi.org/10.1177/1178633720905977
Bosaeed M, Ahmad A, Alali A, Mahmoud E, Alswidan L, Alsaedy A, Aljuhani S, Alalwan B, Alshamrani M, Alothman A. Experience With Ceftolozane-Tazobactam for the Treatment of Serious . Infect Dis (Auckl). 2020 Feb 11;13:1178633720905977. doi: 10.1177/1178633720905977. eCollection 2020. PMID: 32110036; PMCID: PMC7016308.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 90 entries